Mentara Bio develops neurocircuit-targeting therapies and conducts clinical research for neurological disorders such as epilepsy.
Mentara Bio has raised $4.1M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Mentara Bio is headquartered in Durham, United States.
Mentara Bio develops neurocircuit-targeting therapies and conducts clinical research for neurological disorders such as epilepsy.
Mentara Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mentara Bio — Funding & Investors." VCBacked, March 6, 2023, https://www.vcbacked.co/company/mentara-bio. Accessed August 16, 2026.
VCBacked. (2023). Mentara Bio — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/mentara-bio
{{cite web |title=Mentara Bio — Funding & Investors |url=https://www.vcbacked.co/company/mentara-bio |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated